Arbutus Biopharma
ABUS
ABUS
122 hedge funds and large institutions have $154M invested in Arbutus Biopharma in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 19 closing their positions.
Holders
122
Holders Change
+23
Holders Change %
+23.23%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
43
Increased
38
Reduced
22
Closed
19
Calls
$14.4M
Puts
$9.51M
Net Calls
+$4.92M
Net Calls Change
-$893K
Top Buyers
1 |
1
Millennium Management
New York
|
$11.8M |
2 |
BC
2
Brookfield Corp
Toronto,
Ontario, Canada
|
$4.64M |
3 |
3
Nuveen Asset Management
Chicago,
Illinois
|
$7.89M |
4 |
TSC
4
Two Seas Capital
Rye,
New York
|
$3.21M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$17.7M |